Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 1 month ago

CV Disease in Special Populations

Heart Failure
EP 115: Navigating Cultures and Cardiology: Dr Janarthanan Sathananthan's Global Journey
Added: 10 months ago
In this compelling episode of the Parallax Podcast, host Dr Ankur Kalra sits down with Dr Janarthanan Sathananthan, an interventional and structural cardiologist and the Chief Medical Officer of Interventional Cardiology at Boston Scientific. Dr Sathananthan recounts his life's journey, from being born in Sri Lanka during the civil war, and moving to Zimbabwe, New Zealand, Canada, and finally… View more

Intervention
Women's Cardiovascular Health: Addressing Sex Differences, Cardio-Obstetrics & the Heart Team Approach
Author(s): Mirvat Alasnag , Julia Grapsa , Ahmed Krimly Added: 10 months ago
Join this insightful discussion on women's cardiovascular health!ICR3 Guest Editor, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), leads a conversation with Drs Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, UK) and Ahmed Krimly (King Faisal Cardiac Center, SA), authors of a special focus issue on this critical topic.Key themes explored:Disparities in heart failure care for… View more

Demographic

Imaging & Diagnostics
AI and Digital Health in Cardiology
Author(s): Dipti Itchhaporia , Francisco Lopez-Jimenez , David Ouyang Added: 8 months ago
In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia welcomes two leading experts in artificial intelligence in cardiology: Dr David Ouyang from Cedars-Sinai Medical Center in Los Angeles, and Dr Francisco Lopez-Jiminez from the Mayo Clinic in Rochester, MN.Together, they explore the role of artificial intelligence in cardiology, from diagnostics to personalized… View more

Digital Health
EP 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag
Author(s): Mirvat Alasnag , Ankur Kalra Added: 1 year ago
In this week's Parallax, Dr. Ankur Kalra's guest is Dr. Mirvat Alasnag. Dr. Alasnag is an interventional cardiologist at King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Additionally, she serves as the Editor-in-Chief at Current Cardiovascular Imaging Reports and is a member of the Board of Trustees at SCAI. Dr. Alasnag and Dr. Kalra provide a comprehensive review of the key highlights… View more

Intervention
Artificial Intelligence in Cardiology: What You Need to Know in 2024
Author(s): Ami Bhatt Added: 1 year ago
ACC 2024 — Dr Ami B Bhatt, Chief Innovation Officer of ACC, joins us to highlight key information regarding artificial intelligence innovations in cardiology in 2024.Dr Bhatt discusses the potential progress and innovation that artificial intelligence can provide in clinical medicine, including risk predictions, artificial intelligence use in EKGs, large language models and virtual learning… View more

Guidelines & Statements

Imaging & Diagnostics
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Heart Failure

Prevention & Chronic Conditions
Utility of CTCA in CTO PCI
Author(s): Firas Yassin , Jawad Khan , Abdul Mozid , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
AHA 23: Preventive Cardiology in 2023
Author(s): Michael Honigberg Added: 1 year ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation… View more

Guidelines & Statements

Prevention & Chronic Conditions
Erratum: 2024 European Society of Cardiology Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 month ago

Intervention

Prevention & Chronic Conditions